Treatment and outcome of CPD-associated peritonitis

Annals of Clinical Microbiology and Antimicrobials

Volumn 5, Issue , 2006, Pages

  Troidle, Laura ^a   Finkelstein, Fred ^a  

^a New Haven CAPD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEFTAZIDIME; GENTAMICIN; PLACEBO; PSEUDOMONIC ACID; RIFAMPICIN; VANCOMYCIN;

ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BIOFILM; CATHETER INFECTION; CATHETER REMOVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DEPRESSION; DRUG PENETRATION; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMODIALYSIS; HOST RESISTANCE; HUMAN; INCIDENCE; INFECTION RISK; KIDNEY FAILURE; LONG TERM CARE; MINIMUM INHIBITORY CONCENTRATION; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PERITONITIS; PROGNOSIS; RECURRENT INFECTION; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BIOFILMS; HUMANS; PERITONEAL DIALYSIS; PERITONITIS; RISK FACTORS;

EID: 33646251376     PISSN: 14760711     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-5-6     Document Type: Review

References (45)

1. U.S. Renal Data System: USRDS 2005 Annual Data Report. Bethesda, MD: National Institutes of Health, Department of Health and Human Services; 2005.
2. U.S. Renal Data System: USRDS 1996 Annual Data Report. Bethesda, MD: National Institutes of Health, Department of Health and Human Services; 1996.
3. Troidle L, Finkelstein FO: Barriers to CPD Utilization in Network #1, New England. Perit Dial Int. 2006 in press.
4. Maiorca R, Vonesh E, Cavalli R, et al.: A multicenter, selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Perit Dial Int 1991, 11:118-127.
5. Kim DK, Yoo TH, Ryu DR, Xu ZG, Kim HJ, Choi KH, Lee HY, Han DS, Kang SW: Changes in causative organisms and their anti-microbial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int 2004, 24:424-432.
6. Kiernan L, Kliger A, Gorban-Brennan N, Juergensen P, Tesin D, Vonesh E, Finkelstein F: Comparison of continuous ambulatory peritoneal dialysis-related infections with different "y-tubing" exchange systems. J Am Soc Nephrol 1995, 5:1835-1838.
7. Twardowski ZJ, Prowant BF: Current approach to exit-site infections in patients on peritoneal dialysis. Nephrol Dial Transplant 1997, 12:1284-1295.
8. Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R: A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kid Dis 1996, 27:695-700.
9. Thodis E, Bhaskaran S, Pasadakis P, Bargman JM, Vas SI, Oreopoulos DG: Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int 1998, 18:261-270.
10. Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L, Piraino B: Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 2005, 16:539-545.
11. Perez-Fontan M, Garcia-Falcon T, Rosales M, Rodriguez-Carmona A, Adeva M, Rodriguez-Lozano I, Moncalian J: Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin:long-term results. Am J Kid Dis 1993, 22:708-712.
12. The Mupirocin Study Group: Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. J Am Soc Nephrol 1996, 7:2403-2408.
13. Juergensen PH, Juergensen DM, Wuerth DB, Finkelstein SH, Steele TE, Kliger AS, Finkelstein FO: Psychosocial factors and incidence of peritonitis. Adv Perit Dial 1996, 12:196-198.
14. Troidle L, Watnick S, Wuerth DB, Gorban-Brennan N, Kliger AS, Finkelstein FO: Depression and its association with peritonitis in long-term peritoneal dialysis patients. Am J Kid Dis 2003, 42:350-354.
15. Finkelstein E, Jekel J, Troidle L, Gorban-Brennan N, Finkelstein FO, Bia FJ: Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. Am J Kid Dis 2002, 39:1278-1286.
16. Kiernan L, Finkelstein FO, Kliger AS, Gorban-Brennan N, Juergensen P, Mooraki A, Brown E: Outcome of polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kid Dis 1995, 25:461-464.
17. Troidle L, Kliger AS, Goldie SJ, Gorban-Brennan N, Brown E, Fikrig M, Finkelstein FO: Continuous peritoneal dialysis-associated peritonitis of nosocomial origin. Perit Dial Int 1996, 16:505-510.
18. Fried L, Bernardini J, Johnston JR, Piraino B: Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Dial 1996, 7:2176-2182.
19. Mortier S, De Vriese AS, McLoughlin RM, Topley N, Schaub TP, Passlick-Deetjen J, Lameire NH: Effects of conventional and new peritoneal dialysis fluids on leucocyte recruitment in the rat peritoneal membrane. J Am Soc Nephrol 2003, 14:1296-1306.
20. Lameire MS, De Vriese AS: The effects of peritoneal dialysis solutions on peritoneal host defense. Perit Dial Int 2004, 24:123-138.
21. Ahmad S, Sehmi JS, Ahmad-Zaki K, Levy J, Brown EA: Effect of biocompatible dialysate and APD on peritonitis rate and treatment using once daily antibiotics. J Am Soc Nephrol 2005, 16:711A-712A.
22. Zelenitsky S, Barris L, Findlay I, Alfa M, Ariano R, Fine A, Harding G: Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kid Dis 2000, 36:1009-1013.
23. Lye WC, Wong PL, Leong SO, Lee EJ: Isolation of organisms in CAPD peritonitis: a comparison of two techniques. Adv Perit Dial 1994, 10:166-168.
24. Piraino B, Bailie G, Bernardini J, Boeschoten E, Gupta A, Holmes C, Kuijper EJ, Li PKT, Lye WC, Mujais S, Paterson DL, Fontan MP, Ramos A, Schaefer F, Uttley L: Peritoneal dialysis-related infections recommendations:2005 update. Perit Dial Int 2005, 25:107-131.
25. Troidle L, Kliger AS, Gorban-Brennan N, Fikrig M, Golden M, Finkelstein FO: 9 episodes of CPD-associated peritonitis with vancomycin resistant enterococci. Kid Int 1996, 50:1368-1372.
26. Salzer W: Antimicrobial-resistant gram-positive bacteria in PD peritonitis and the newer antibiotics used to treat them. Perit Dial Int 2005, 25:313-319.
27. Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR: Emergence of vancomycin resistance in Staphylococcus aureus. New Eng J Med 1999, 340:493-501.
28. Troidle L, Gorban-Brennan N, Kliger A, Finkelstein F: Differing outcomes of gram-positive and gram-negative peritonitis. Am J Kid Dis 1998, 32:623-628.
29. Bunke CM, Brier ME, Golper TA: Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 peritonitis study. Kid Int 1997, 52:524-529.
30. Troidle L, Kliger A, Gorban-Brennan N, Finkelstein F: Course of creactive protein during continuous peritoneal dialysis-associated peritonitis. Nephrology 2005, 10:442-445.
31. Goldie SJ, Kiernan-Troidle L, Torres C, Gorban-Brennan N, Dunne D, Kliger AS, Finkelstein FO: Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kid Dis 1996, 28:86-91.
32. Krishnan M, THodis E, Ikonomopoulos D, Vidgen E, Chu M, Bargman JM, Vas SI, Oreopoulos DG: Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int 2002, 22:573-581.
33. Troidle L, Gorban-Brennan N, Finkelstein FO: Outcome of patients on chronic peritoneal dialysis undergoing peritoneal catheter removal because of peritonitis. Adv Perit Dial 2005, 21:98-101.
34. Szeto CC, Chow KM, Wong TY, Leung CB, Wang AY, Lui SF, Li PK: Feasibility of resuming peritoneal dialysis after severe peritonitis and Tenckhoff catheter removal. J Am Soc Nephrol 2002, 13:1040-1045.
35. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, Divino Filho JC, Vonesh E, Van Bree M, EAPOS Group: Survival of functionally anuric patients on automated peritoneal dialysis: the European APD outcome study. J Am Soc Nephrol 2003, 14:2918-2957.
36. Troidle LK, Gorban-Brennan N, Kliger AS, Finkelstein FO: Continuous cycler therapy, manual peritoneal dialysis therapy, and peritonitis. Adv Perit Dial 1998, 14:137-141.
37. Yishak A, Bernardini J, Fried L, Piraino B: The outcome of peritonitis in patients on automated peritoneal dialysis. Adv Perit Dial 2001, 17:205-208.
38. Oo T, Roberts TL, Collins AJ: A comparison of peritonitis rates from the United States Renal Data System Database: CAPD versus continuous cycling peritoneal dialysis patients. Am J Kid Dis 2005, 45:372-380.
39. Troidle L, Finkelstein FO: Peritonitis and automated peritoneal dialysis: a therapeutic conundrum? Perit Dial Int 2005, 25:142-145.
40. Manley HJ, Bailie GR: Automated peritoneal dialysis symposium treatment of peritonitis in APD: pharmacokinetic principles. Semin Dial 2002, 15:418-421.
41. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
42. Dasgupta MK: Biofilms and infection in dialysis patients. Semin Dial 2002, 15:338-346.
43. Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich: The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 2003, 112:1466-1477.
44. Sepandj F, Ceri H, Gibb A, Read R, Olson M: Minimum inhibitory concentration (MIC) versus biofilm eliminatory concentration (MBEC) in evaluation of antibiotic sensitivity of gram-negative bacilli causing peritonitis. Perit Dial Int 2004, 24:65-67.
45. Khaled GH, Finkelstein FO, Carey HB, Wardlaw SC, Kliger AS, Edberg SC: Method for studying development of colonization and infection of dialysis catheters. Adv Perit Dial 2001, 17:163-171.